Rhumbline Advisers Merck & Co., Inc. Transaction History
Rhumbline Advisers
- $113 Billion
- Q2 2025
A detailed history of Rhumbline Advisers transactions in Merck & Co., Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 4,109,208 shares of MRK stock, worth $355 Million. This represents 0.29% of its overall portfolio holdings.
Number of Shares
4,109,208
Previous 4,492,983
8.54%
Holding current value
$355 Million
Previous $403 Million
19.34%
% of portfolio
0.29%
Previous 0.39%
Shares
33 transactions
Others Institutions Holding MRK
# of Institutions
3,840Shares Held
1.96BCall Options Held
29.2MPut Options Held
30M-
Vanguard Group Inc Valley Forge, PA253MShares$21.9 Billion0.34% of portfolio
-
Black Rock Inc. New York, NY207MShares$17.9 Billion0.59% of portfolio
-
State Street Corp Boston, MA118MShares$10.2 Billion0.36% of portfolio
-
Wellington Management Group LLP Boston, MA76.9MShares$6.64 Billion1.15% of portfolio
-
Geode Capital Management, LLC Boston, MA59MShares$5.09 Billion0.34% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $219B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...